Eversept Partners, LP has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $1.29 Billion distributed in 86 stocks.
Among their holdings, we can observe that their the top five positions include companies like: United Therapeutics Corp with a value of $106M, Natera, Inc. with a value of $83.6M, Vera Therapeutics, Inc. with a value of $81.3M, Syndax Pharmaceuticals Inc with a value of $53.4M, and Vaxcyte, Inc. with a value of $51.2M.
Examining the 13F form we can see an increase of $298M in the current position value, from $993M to 1.29B.
Eversept Partners, LP is based out at New York, NY
Below you can find more details about Eversept Partners, LP portfolio as well as his latest detailed transactions.
Portfolio value
$1.29 Billion
Healthcare: $1.14 Billion
ETFs: $138 Million
Basic Materials: $11.5 Million
Financial Services: $535,000
Stock Holdings Table Market Cap. of $300 Millions to $2 Billions
